广西社区肝癌高危人群队列研究的质量控制
[Abstract]:Background: primary liver cancer (PLC) is one of the most common malignant tumors in the world and China. Its incidence is the fifth largest in the world. The mortality rate is the third in the world. In recent years, the incidence and mortality rate are increasing. The study shows that the occurrence and development of liver cancer are related to a variety of risk factors, among them, the occurrence and development of liver cancer are related to many risk factors. HBV infection is the most important risk factor for liver cancer in China. Epidemiological cohort studies collect data mostly in the way of field investigation. The accuracy of data data determines the correctness of the research conclusions. The acquisition of some data is not repeatable and requires a one-time acquisition. If the quality control of fruit is not good, it will cause a large number of queues. It is important for the whole process of cohort study for high risk population of HCC. Although there have been some literature on the quality control of follow-up and the quality control of specimens at home and abroad, there are some domestic and foreign countries. A rare literature report on the overall quality control of high risk cohort study. Objective: To explore the quality control system for cohort study of high risk population in Guangxi community, to provide accurate data and biological specimens for the follow-up of tumor markers or genes, and to provide more scientific and rational research for the sustainable development of the research. Methods: a cohort of high risk groups of liver cancer with positive HBsAg and HBcAb was established by detecting the two half of hepatitis B as a preliminary screening method. A follow-up follow-up was conducted every half year to detect the serum hepatitis B two to half, liver function, alpha fetoprotein and liver B ultrasonography, collect blood samples and data, and detect AFP and / or liver B ultrasound examination. A timely examination of the abnormality was conducted, and the diagnosis and treatment were made as early as possible with other clinical examinations. This article from the investigation of the first stage (the design of the study, the selection of the site and the crowd, the work manual and the quality control documents, the quality control system), and the preparation of the investigation stage (the pre investigation test of the survey registration form) The quality control of the high risk population of liver cancer was discussed in many aspects, such as publicity mobilization, field survey, field sampling, liver B ultrasound examination, blood sample transport separation and preservation, laboratory testing, clinical diagnosis of liver cancer, data management, quality feedback and so on. Results: in November 2010, it was built up to December 31, 2015. A cohort of high risk people for liver cancer was set up and followed up for 7 times. A total of 2665 cases of high risk population of liver cancer were queued, 2665 were collected from the baseline survey list, and 7021 of the blood samples were collected. After training, the staff basically grasp the whole process and the quality control method of the cohort study, and can complete the work tasks well. The investigation registration form has the characteristics of reliability, validity and applicability. The survey project is scientific and reasonable, and it has proved to be able to meet the needs of the research and investigation of this queue. It has high quality; the quality control method of laboratory testing ensures the accuracy of the results; the quality of the blood samples is good enough to meet the needs of laboratory testing and subsequent tumor markers or gene studies; the use of classified markers to store blood samples; the establishment of a archival data room, special management, screening and reexamination of data has been basically lost. In the clinical diagnosis of 8 cases of liver cancer (5 cases of early liver cancer and 3 cases of advanced liver cancer), and the annual follow-up compliance of the high risk population of liver cancer is between 51.16%-76.89%. Conclusion: in the cohort study of high risk population of liver cancer in Guangxi community, the factors affecting the accuracy of data and samples are multifaceted, data and samples are collected. Although it needs a lot of manpower and material resources, it is the key to ensure the quality of the data and sample of the queue to study the reasonable operation flow and quality control scheme according to the actual situation.
【学位授予单位】:广西医科大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R735.7
【相似文献】
相关期刊论文 前10条
1 彭清英,卢平,宋彩云;多弹头射频治疗肝癌病人的护理[J];护理研究;2001年01期
2 ;目前治疗肝癌有哪些方法?怎样选择?[J];上海预防医学杂志;2002年11期
3 丁亚香;中晚期肝癌病人疼痛的护理体会[J];右江医学;2002年05期
4 刘永智,刘庆华;10对同胞兄妹死于肝癌的报告[J];河南肿瘤学杂志;2003年06期
5 赵海艳;1例肝癌病人临终关怀的护理[J];蛇志;2005年01期
6 高建梅;贾国庆;陈妍;;三维适形放射治疗肝癌的研究进展[J];内蒙古医学杂志;2006年08期
7 杨桂华;王奉宝;张馨丹;;肝癌病人的护理[J];临床和实验医学杂志;2006年11期
8 谢月琛;;68例肝癌病人的临终关怀[J];家庭护士;2008年02期
9 王秀丽;;晚期肝癌病人的护理[J];家庭护士;2008年13期
10 严翩;;肝癌最喜欢折腾哪些人?[J];肝博士;2009年04期
相关会议论文 前10条
1 罗伟玲;陈泽红;;在肝癌病人中开展健康教育的几点体会[A];全国护理临床研究学术交流暨专题讲座会议论文会编[C];2001年
2 汤钊猷;;提高肝癌疗效的探讨[A];2008年浙江省外科学术年会论文汇编[C];2008年
3 郑树森;;肝癌的诊治进展[A];2009年浙江省外科学学术年会论文汇编[C];2009年
4 曾文铤;谢青山;朱科伦;马佩球;刘衍民;;射频毁损治疗中晚期肝癌的初步研究(附12例临床报告)[A];2000全国肿瘤学术大会论文集[C];2000年
5 宋恕平;盛立军;刘波;;肝癌药物治疗的新探索[A];中国临床肿瘤学教育专辑(2001)——中国抗癌协会临床肿瘤学协作中心(CSCO)第五届年会论文集[C];2001年
6 陆益钱;;肝癌病人的健康教育体会[A];第一届全国肿瘤护理学术会议论文集[C];2001年
7 杨秉辉;;肝癌综合治疗的选择[A];第三届中国肿瘤学术大会教育论文集[C];2004年
8 谈菊萍;;肝癌病人的心理表现及护理对策[A];全国肿瘤护理学术交流暨专题讲座会议论文汇编[C];2005年
9 曾带娣;岳建荣;王翠霞;田月月;;肝癌病人心理变化的护理对策[A];全国传染病护理学术交流暨专题讲座会议论文汇编[C];2006年
10 林云萍;;肝癌病人的心理特点及护理对策[A];全国肿瘤护理学术交流暨专题讲座会议论文汇编[C];2008年
相关重要报纸文章 前10条
1 本报记者 沙文茹 本期专家 李基业;肝癌术后如何康复[N];中国消费者报;2003年
2 记者 唐先武邋通讯员 黄显斌;我科学家在肝癌发病机制研究中获新进展[N];科技日报;2007年
3 副主任医师 周德瑞;肝癌病人能生育喂奶吗[N];卫生与生活报;2007年
4 通讯员 程守勤;五类危险人群尤需警惕肝癌[N];家庭医生报;2009年
5 本报记者 李娜;肝癌高发真相探源[N];吉林日报;2013年
6 黄静 李媛媛;丙肝发展成肝癌速度或更快[N];人民政协报;2013年
7 记者 黄才刚;肝癌宜因人施治[N];健康报;2000年
8 钟肖协;肝癌“偏爱”哪些人[N];陕西日报;2000年
9 黄显斌邋唐明山;我科学家在肝癌发病机制研究中取得重大进展[N];光明日报;2007年
10 福星;肝癌如何早发现[N];民族医药报;2007年
相关博士学位论文 前10条
1 王明海;Musashi-2通过Wnt/β-catenin信号通路促进乙肝病毒相关性肝癌进展的作用机制研究[D];山东大学;2015年
2 周少来;CXCL5促进中性粒细胞浸润及其在肝癌微环境中的作用和机制研究[D];复旦大学;2014年
3 刘艳丰;PROX1通过上调HIF-1α的表达及蛋白稳定性促进肝癌的转移[D];复旦大学;2014年
4 景莹;拷贝数变异基因SERPINA5和SMARCA4在肝癌细胞中功能及机制研究[D];复旦大学;2014年
5 赵琪;Ftx IncRNA编码的miR-545/374a在HBV相关的肝癌中的变化及其意义[D];山东大学;2015年
6 上官辉;肝癌易感相关基因及组织基因表达谱生物信息学分析[D];南方医科大学;2015年
7 袁星;釫酮类天然产物异巴西红厚壳素的抗肝癌活性及其作用机制研究[D];第二军医大学;2015年
8 卢杉;长链非编码RNA:HOXD-AS1在肝癌中的功能和机制研究[D];第二军医大学;2015年
9 冀彤;IL6、TNFα和TNFR1在卵圆细胞增殖和炎症诱发肝癌中作用和机制的研究[D];浙江大学;2015年
10 赵昌林;CD4~+CXCR5~+CD57~+T细胞在肝癌发病中的作用及解毒抗癌方干预的研究[D];暨南大学;2015年
相关硕士学位论文 前10条
1 陈曼;Ki67、VEGF、P53在移植后肝癌复发中的预测价值及化疗对移植后复发肝癌患者的预后影响[D];福建中医药大学;2015年
2 杨帅;ZNF545在肝癌中的表观遗传学改变及功能的研究[D];中国人民解放军医学院;2015年
3 齐冰;肝癌患者肝脏中乙醇脱氢酶和乙醛脱氢酶活性变化[D];郑州大学;2015年
4 杨文;RNF2抑制肝癌细胞的恶性生物学行为及其与MANF相互作用的研究[D];安徽医科大学;2015年
5 王显腾;A20抑制TNF-α诱导的肝癌细胞的迁移[D];山东大学;2015年
6 卢乐乐;NG2在肝癌中的表达以及与患者预后相关性研究[D];第三军医大学;2015年
7 杨西胜;MiR-200a/ZEB2调控肝癌干性样细胞恶性表型转化的机制研究[D];第四军医大学;2015年
8 禹鸿鸣;醛缩酶B在索拉非尼治疗肝癌的耐药作用研究[D];第二军医大学;2015年
9 张春忙;肝螺杆菌对肝癌细胞侵袭能力的影响及分子机制的初步研究[D];南方医科大学;2015年
10 杜敏;微脉管浸润对小肝癌病人预后的影响及MicroRNA对微脉管浸润的预测作用[D];复旦大学;2014年
,本文编号:2148558
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2148558.html